Q2 2021 EPS Estimates for GoHealth, Inc. Reduced by Analyst (NASDAQ:GOCO)

GoHealth, Inc. (NASDAQ:GOCO) – Analysts at Truist Securiti dropped their Q2 2021 earnings per share (EPS) estimates for GoHealth in a research note issued to investors on Wednesday, May 12th. Truist Securiti analyst T. Sommer now expects that the company will post earnings of ($0.06) per share for the quarter, down from their previous forecast of ($0.03). Truist Securiti also issued estimates for GoHealth’s Q3 2021 earnings at ($0.01) EPS.

A number of other analysts have also weighed in on GOCO. Morgan Stanley upped their price objective on GoHealth from $13.00 to $14.00 and gave the stock an “equal weight” rating in a research report on Friday. Raymond James cut their price objective on GoHealth from $15.00 to $14.00 and set an “outperform” rating on the stock in a research report on Monday. Truist lowered their target price on shares of GoHealth from $26.00 to $20.00 and set a “buy” rating for the company in a research note on Thursday, May 13th. Zacks Investment Research upgraded shares of GoHealth from a “sell” rating to a “hold” rating in a research note on Monday. Finally, Credit Suisse Group lowered their target price on shares of GoHealth from $19.00 to $18.00 and set an “outperform” rating for the company in a research note on Monday. Two investment analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The stock currently has an average rating of “Buy” and an average price target of $19.64.

GoHealth stock opened at $11.21 on Monday. GoHealth has a twelve month low of $9.82 and a twelve month high of $26.25. The stock’s fifty day simple moving average is $11.85 and its 200-day simple moving average is $12.76.

GoHealth (NASDAQ:GOCO) last posted its quarterly earnings data on Wednesday, May 12th. The company reported ($0.02) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.01). The firm had revenue of $204.20 million during the quarter, compared to analyst estimates of $176.41 million. The business’s revenue for the quarter was up 44.8% on a year-over-year basis.

Several large investors have recently made changes to their positions in the company. Treasurer of the State of North Carolina raised its holdings in shares of GoHealth by 5.8% in the first quarter. Treasurer of the State of North Carolina now owns 16,130 shares of the company’s stock valued at $189,000 after buying an additional 880 shares during the last quarter. Rhumbline Advisers raised its holdings in shares of GoHealth by 5.5% in the fourth quarter. Rhumbline Advisers now owns 33,214 shares of the company’s stock valued at $454,000 after buying an additional 1,740 shares during the last quarter. Public Employees Retirement System of Ohio raised its holdings in shares of GoHealth by 14.6% in the first quarter. Public Employees Retirement System of Ohio now owns 23,361 shares of the company’s stock valued at $273,000 after buying an additional 2,982 shares during the last quarter. Rafferty Asset Management LLC raised its holdings in shares of GoHealth by 28.9% in the first quarter. Rafferty Asset Management LLC now owns 22,164 shares of the company’s stock valued at $259,000 after buying an additional 4,963 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in shares of GoHealth by 1.9% in the first quarter. Northern Trust Corp now owns 294,994 shares of the company’s stock valued at $3,449,000 after buying an additional 5,591 shares during the last quarter. 26.55% of the stock is owned by institutional investors and hedge funds.

In other news, COO Shane E. Cruz sold 75,000 shares of the company’s stock in a transaction dated Monday, April 26th. The shares were sold at an average price of $12.17, for a total value of $912,750.00. Following the completion of the sale, the chief operating officer now directly owns 167,843 shares of the company’s stock, valued at $2,042,649.31. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Anita Pramoda bought 10,370 shares of GoHealth stock in a transaction dated Friday, March 12th. The stock was acquired at an average cost of $9.99 per share, with a total value of $103,596.30. Following the completion of the acquisition, the director now directly owns 22,275 shares of the company’s stock, valued at approximately $222,527.25. The disclosure for this purchase can be found here.

GoHealth Company Profile

GoHealth, Inc operates as a health insurance marketplace and Medicare focused digital health company in the United States. It operates through four segments: MedicareÂInternal; MedicareÂExternal; Individual and Family Plans (IFP) and OtherÂInternal; and Individual and Family Plans and OtherÂExternal.

Featured Article: How a Put Option Works

Earnings History and Estimates for GoHealth (NASDAQ:GOCO)

Receive News & Ratings for GoHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GoHealth and related companies with MarketBeat.com's FREE daily email newsletter.